HypoPet is a Swiss biotech company engaged in the research, development, manufacture and licensing of therapeutic vaccines for major unmet needs in companion animal medicine; allergy, inflammation, pain, cardiovascular and metabolic disease and cancer. HypoPet has developed and patented a recombinant virus-like particle vaccine platform, which can be used to induce long-lived antibodies that specifically target key molecules that drive chronic diseases. With our technology we aim to leverage the profound success achieved with human monoclonal antibodies into cost-effective treatments for pets.
View Top Employees from HypoPet AG| Website | http://www.hypopet.ch |
| Revenue | $6 million |
| Employees | 5 (1 on RocketReach) |
| Founded | 2013 |
| Address | Wagistrasse 12, Schlieren, Zurich 8952, CH |
| Technologies |
HTML,
Nginx,
Hostpoint
+1 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pet, Drug Discovery, Pharmaceuticals, Community and Lifestyle, Healthcare |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular HypoPet AG employee's phone or email?
HypoPet AG Questions
The HypoPet AG annual revenue was $6 million in 2024.
Franziska Zabel is the Head of Immunological Research of HypoPet AG.
1 people are employed at HypoPet AG.
HypoPet AG is based in Schlieren, Zurich.
The NAICS codes for HypoPet AG are [3254, 32541, 32, 325].
The SIC codes for HypoPet AG are [28, 283].
Top HypoPet AG Employees
Related Companies
